According to a market report by Lucintel, the future of the global circRNA synthesis service market looks promising with opportunities in the drug discovery, cell therapy, vaccine R&D, and disease mechanism markets. The global circRNA synthesis service market is expected to grow with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing investment in biotechnology and genomics research and the growing focus on personalized medicine and precision therapy.
A more than
150-page report to understand trends, opportunity and forecast in global circRNA
synthesis service market to 2031 by type (chemical synthesis method, ligase
method, and ribozyme method), application (drug discovery, cell therapy,
vaccine r&d, and disease mechanism), and region (North America, Europe,
Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, the chemical synthesis method is
expected to witness the highest growth over the forecast period.
Within the
application category, drug discovery is expected to witness the highest growth.
Download
sample by clicking on circRNA
synthesis service market.
In terms
of region, North America is expected to witness the highest growth over the
forecast period due to high investment in biotechnology and a significant focus
on RNA-based therapeutics.
GenScript,
Guangzhou IGE Biotechnology, Geneseed, Azenta Life Sciences, Beyotime are the
major suppliers in the circRNA
synthesis service market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment